ArticleJournal of translational medicine2026
Disrupting the epithelial-effector axis in type 2 inflammation: the strategic superiority of dual TSLP/IL-13 blockade in achieving immunological reset.
Yu Han et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.